( Lancet 2023, NCT04982575 [12] ) randomised 92 adults with type 2 diabetes on metformin, with or without an SGLT2 inhibitor, 1:1:1 to CagriSema (n=31), semaglutide (n=31), or cagrilintide (n=30), all escalated to 2.4 mg, across 17 US sites over 32 weeks
[2] This is the closest the field has come to direct human validation, and the results are encouraging without being definitive
Pillai, R., Hayashi, M., Zavitsanou, A
Minoxidil opens potassium channels and increases VEGF
Estrogen Receptors: Controlling Genes So what does estrogen do in cells
During your consultation, our experienced medical team will help you select the treatment that best fits your health goals